At InkVivo we combine our patented biomaterial platform with our advanced manufacturing approach to produce delivery systems that ensure a temporal controlled release of active ingredients (e.g., small molecules, biologics, and micronutrients). With our platform technology we cover a broad range of clinical challenges in the pharma and nutraceutical field. Initially, we focus on gastric delivery systems.
InkVivo's USP is to support our partners to develop new drug delivery systems; to repurpose and reformulate existing drugs; and to extend the lifecycle of patent expiring products. Overall, InkVivo's biofabrication strategy has the potential to improve a broad range of products used in our daily life with a special focus on health, nutrition, and sustainability.
InkVivo's USP is to support our partners to develop new drug delivery systems; to repurpose and reformulate existing drugs; and to extend the lifecycle of patent expiring products. Overall, InkVivo's biofabrication strategy has the potential to improve a broad range of products used in our daily life with a special focus on health, nutrition, and sustainability.
Location: Switzerland
Total raised: $1.38M
Investors 1
| Date | Name | Website |
| 19.03.2023 | Venture Ki... | venturekic... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.08.2025 | - | $1.38M | TiVenture |
Mentions in press and media 10
| Date | Title | Description |
| 31.10.2025 | More than 20 Swiss biotech companies to exhibit at Bio Europe | Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi... |
| 13.08.2025 | InkVivo Technologies secures CHF 1.1 million | InkVivo, a Swiss biotech spin-off from ETH Zurich, addresses a critical challenge in drug development: improving how medicines are formulated and delivered to enhance efficacy and patient outcomes. Its proprietary polymer platform enables ... |
| 26.03.2025 | Venture Leaders Biotech 2025 cohort revealed | After reviewing over 70 applications, the jury of investors and biotech experts selected the ten startups to participate in the Boston roadshow, one of the world’s leading life science hubs. The Venture Leaders program will allow the selec... |
| 25.04.2024 | Talent Kick expands program following two successful editions | Talent Kick is a cross-university program dedicated to helping students at Swiss-based Universities find and build an interdisciplinary co-founder team, and get hands-on entrepreneurial experience during their studies to become responsible... |
| 23.01.2023 | CH 40,000 for a novel drug delivery system to prevent stenosis, a patented biomaterial platform revolutionizing the way drugs can be administered to patients, and mangrove restoration to speed-up carb... | ArtemiX Biotech: a novel drug delivery system to prevent stenosis Chronic kidney disease (CKD) is a serious, life-threatening, and growing health problem affecting millions of patients worldwide. Patients with CKD have significantly reduced... |
| 12.10.2022 | Fifteen Talent Kick projects enter the next level | |
| 27.09.2022 | Startups turning waste into value, developing an innovative drilling robot, a sustainable cellulose white pigment, providing innovative biomaterial, offering crowdsourced data labeling using the mobil... | Gaia Technologies: Turning waste into value The cosmetic, food, and pet food industries eagerly look for new cost-effective natural ingredients coming from sustainable supply chains and equaling or surpassing the performance of current stan... |
| 17.06.2022 | Venture Day Basel presents 18 startups | |
| 20.05.2022 | Startup Days break a record | |
| - | InkVivo | “InkVivo Technologies” |